DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Pfeifer H. Wassmann B. Bethge W. et al.
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.
Leukemia 2013;
27: 1254-1262
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.